What are the major opportunities in the Oral Biologics & Biosimilar Drugs market? What are the strategies for the Oral Biologics & Biosimilar Drugs market?

For detailed insights on the major opportunities and strategies in the Oral Biologics & Biosimilar Drugs market, Read More

How does the Oral Biologics & Biosimilar Drugs market relate to the overall economy and other similar markets?

For detailed insights on Oral Biologics & Biosimilar Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Oral Biologics & Biosimilar Drugs market growth? SWOT analysis of the Oral Biologics & Biosimilar Drugs market.

For detailed insights on the key dynamics influencing the Oral Biologics & Biosimilar Drugs market growth and SWOT analysis of the Oral Biologics & Biosimilar Drugs industry, Read More

Oral Biologics & Biosimilar Drugs Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Oral Biologics & Biosimilar Drugs Market Report 2026

Name: Oral Biologics & Biosimilar Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others ), By Molecule Type (Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Oral Biologics & Biosimilar Drugs Market Overview

• Oral Biologics & Biosimilar Drugs market size has reached to $8.6 billion in 2025

• Expected to grow to $17.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%

• Growth Driver: Rising Prevalence Of Chronic Diseases Driving Growth In The Oral Biologics And Biosimilar Drugs Market

• Market Trend: Advancements In Oral Biologics For Obesity Management

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Oral Biologics & Biosimilar Drugs Market?

A biosimilar refers to a medication that closely resembles a biological medication in both structure and function. A biological drug, however, is a treatment created using a biological system, such as yeast, bacteria, or animal cells. A biological product is considered 'biosimilar' if it is extremely similar to and bears no discernible clinical differences from an FDA-approved reference product already in use.

The main therapy types are oral biologics and biosimilar lymphocyte modulators, interleukin inhibitors, and tumor necrosis factor-alpha inhibitors. Interleukin inhibitors are immunosuppressive drugs that stop interleukins from working. Interleukins are a family of cytokines produced by lymphocytes, monocytes, macrophages, and a few other cells. They play an important role in immune system regulation. The various diseases treated include asthma, Crohn’s disease, carcinoma, arthritis, diabetes, multiple myeloma, enterocolitis, multiple sclerosis, sarcoma, psoriasis, and others, by vaccines, proteins and peptides, monoclonal antibodies, and others. The drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Oral Biologics & Biosimilar Drugs Market Global Report 2026 Market Report bar graph

What Is The Oral Biologics & Biosimilar Drugs Market Size and Share 2026?

The oral biologics & biosimilar drugs market size has grown exponentially in recent years. It will grow from $8.6 billion in 2025 to $10.41 billion in 2026 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to limited availability of oral biologics, reliance on injectable biologics, rising prevalence of autoimmune and inflammatory diseases, increasing patient demand for cost-effective therapies, early approvals of monoclonal antibody drugs.

What Is The Oral Biologics & Biosimilar Drugs Market Growth Forecast?

The oral biologics & biosimilar drugs market size is expected to see rapid growth in the next few years. It will grow to $17.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to development of next-generation oral biologics, expansion of biosimilar pipeline, increasing adoption of combination therapies, growing digital health platforms for patient monitoring, rising regulatory support for biosimilar approvals. Major trends in the forecast period include rising adoption of oral biologics and biosimilar drugs, increasing focus on chronic disease management using biologics, expansion of hospital and retail pharmacy distribution channels, growth in patient awareness and acceptance of biosimilars, development of targeted therapies for autoimmune and inflammatory diseases.

Book your 30 minutes free consultation with our research experts

Global Oral Biologics & Biosimilar Drugs Market Segmentation

1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors

2) By Disease: Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others

3) By Molecule Type: Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Lymphocyte Modulators: Fingolimod, Ocrelizumab, Natalizumab

2) By Interleukin Inhibitors: Ustekinumab, Secukinumab, Guselkumab

3) By Tumor Necrosis Factor-Alpha Inhibitors: Adalimumab, Certolizumab Pegol, Golimumab

What Is The Driver Of The Oral Biologics & Biosimilar Drugs Market?

The rising prevalence of chronic diseases such as arthritis, asthma, and cancer is expected to be a major driver of the oral biologics and biosimilar market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases, and biologics are increasingly used to treat these chronic diseases. Biologics activate the immune system response against cancer cells thus helping the immune system to eliminate the cancer cells from the body. For instance, in May 2023 According to a United Nations article, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60%. Therefore, the rise in the prevalence of chronic diseases is projected to propel the demand for biologics and biosimilars, thus driving the oral biologics & biosimilar drugs industry growth.

Key Players In The Global Oral Biologics & Biosimilar Drugs Market

Major companies operating in the oral biologics & biosimilar drugs market are Novartis International AG, Rani Therapeutics Holdings Inc., Eli Lilly and Company, AstraZeneca plc, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals Inc., BiosanaPharma, Entera Bio Ltd., Allergan plc, Emisphere Technologies Inc., Enteris BioPharma Inc., Chiasma Inc., Allena Pharmaceuticals Inc., Gelgen Corporation, 3SBio Inc., Innovent Biologics Inc., GlaxoSmithKline PLC, Concord Biotech Limited, Sanofi S.A., F. Hoffmann-La Roche Ltd., Allergan Pharmaceuticals International Limited, Mylan N.V., Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd.

Global Oral Biologics & Biosimilar Drugs Market Trends and Insights

Major companies operating in the oral biologics and biosimilar markets are focusing on innovative products, such as incretin triagonists, to enhance patient outcomes, improve drug efficacy, and provide alternatives to injectable therapies. Incretin triagonists are drugs that simultaneously activate three hormone receptors GLP-1, GIP, and glucagon, which help regulate blood sugar, appetite, and metabolism. For instance, in October 2024, Rani Therapeutics Holdings Inc., a US-based biotechnology company, released new preclinical pharmacokinetic data supporting the transenteric delivery of a GLP-1 incretin triagonist. Their RaniPill, an oral capsule designed for delivering biologics traditionally requiring injections, successfully delivered an incretin triagonist targeting GLP-1, GIP, and glucagon receptors key targets in obesity treatment. The RaniPill demonstrated comparable effectiveness to subcutaneous injections, offering a needle-free alternative with high bioavailability and flexible dosing, establishing it as a promising solution for obesity drug candidates.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Oral Biologics & Biosimilar Drugs Market?

In August 2023, Oramed Pharmaceuticals Inc., a US-based pharmaceutical company, formed a joint venture with Hefei Tianhui Incubator of Technologies Co., Ltd. (HTIT) to develop and commercialize oral drug products. The collaboration aims to advance the development of innovative oral formulations, improve patient adherence, and expand access to orally administered therapies, enhancing treatment options while fostering growth and innovation in the oral drug delivery sector. Hefei Tianhui Incubator of Technologies Co., Ltd. (HTIT) is a China-based healthcare technology and innovation company focused on developing next-generation pharmaceutical solutions.

Regional Insights

North America was the largest region in the oral biologics and biosimilar drugs market in 2025. The Middle East is expected to be the fastest growing region in the oral biologics & biosimilar drugs market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oral Biologics & Biosimilar Drugs Market?

The oral biologics and biosimilar market consist of sales of therapeutic proteins, cystic fibrosis, somatic cells, and allergenics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oral Biologics & Biosimilar Drugs Market Report 2026?

The oral biologics & biosimilar drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oral biologics & biosimilar drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Oral Biologics & Biosimilar Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$10.41 billion
Revenue Forecast In 2035	$17.17 billion
Growth Rate	CAGR of 21.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapy, Disease, Molecule Type, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Novartis International AG, Rani Therapeutics Holdings Inc., Eli Lilly and Company, AstraZeneca plc, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals Inc., BiosanaPharma, Entera Bio Ltd., Allergan plc, Emisphere Technologies Inc., Enteris BioPharm
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oral Biologics & Biosimilar Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oral Biologics & Biosimilar Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oral Biologics & Biosimilar Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oral Biologics & Biosimilar Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Oral Biologics And Biosimilar Drugs

4.2.2 Increasing Focus On Chronic Disease Management Using Biologics

4.2.3 Expansion Of Hospital And Retail Pharmacy Distribution Channels

4.2.4 Growth In Patient Awareness And Acceptance Of Biosimilars

4.2.5 Development Of Targeted Therapies For Autoimmune And Inflammatory Diseases

5. Oral Biologics & Biosimilar Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Retail Pharmacies

5.3 Online Pharmacies

5.4 Specialty Clinics

5.5 Biopharmaceutical Companies

6. Oral Biologics & Biosimilar Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oral Biologics & Biosimilar Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oral Biologics & Biosimilar Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oral Biologics & Biosimilar Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oral Biologics & Biosimilar Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oral Biologics & Biosimilar Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oral Biologics & Biosimilar Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oral Biologics & Biosimilar Drugs Market Segmentation

9.1. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors

9.2. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others

9.3. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types

9.4. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Lymphocyte Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fingolimod, Ocrelizumab, Natalizumab

9.6. Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ustekinumab, Secukinumab, Guselkumab

9.7. Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Tumor Necrosis Factor-Alpha Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adalimumab, Certolizumab Pegol, Golimumab

10. Oral Biologics & Biosimilar Drugs Market Regional And Country Analysis

10.1. Global Oral Biologics & Biosimilar Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oral Biologics & Biosimilar Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oral Biologics & Biosimilar Drugs Market

11.1. Asia-Pacific Oral Biologics & Biosimilar Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oral Biologics & Biosimilar Drugs Market

12.1. China Oral Biologics & Biosimilar Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oral Biologics & Biosimilar Drugs Market

13.1. India Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oral Biologics & Biosimilar Drugs Market

14.1. Japan Oral Biologics & Biosimilar Drugs Market Overview

14.2. Japan Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oral Biologics & Biosimilar Drugs Market

15.1. Australia Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oral Biologics & Biosimilar Drugs Market

16.1. Indonesia Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oral Biologics & Biosimilar Drugs Market

17.1. South Korea Oral Biologics & Biosimilar Drugs Market Overview

17.2. South Korea Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oral Biologics & Biosimilar Drugs Market

18.1. Taiwan Oral Biologics & Biosimilar Drugs Market Overview

18.2. Taiwan Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oral Biologics & Biosimilar Drugs Market

19.1. South East Asia Oral Biologics & Biosimilar Drugs Market Overview

19.2. South East Asia Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oral Biologics & Biosimilar Drugs Market

20.1. Western Europe Oral Biologics & Biosimilar Drugs Market Overview

20.2. Western Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oral Biologics & Biosimilar Drugs Market

21.1. UK Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oral Biologics & Biosimilar Drugs Market

22.1. Germany Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oral Biologics & Biosimilar Drugs Market

23.1. France Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oral Biologics & Biosimilar Drugs Market

24.1. Italy Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oral Biologics & Biosimilar Drugs Market

25.1. Spain Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oral Biologics & Biosimilar Drugs Market

26.1. Eastern Europe Oral Biologics & Biosimilar Drugs Market Overview

26.2. Eastern Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oral Biologics & Biosimilar Drugs Market

27.1. Russia Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oral Biologics & Biosimilar Drugs Market

28.1. North America Oral Biologics & Biosimilar Drugs Market Overview

28.2. North America Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oral Biologics & Biosimilar Drugs Market

29.1. USA Oral Biologics & Biosimilar Drugs Market Overview

29.2. USA Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oral Biologics & Biosimilar Drugs Market

30.1. Canada Oral Biologics & Biosimilar Drugs Market Overview

30.2. Canada Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oral Biologics & Biosimilar Drugs Market

31.1. South America Oral Biologics & Biosimilar Drugs Market Overview

31.2. South America Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oral Biologics & Biosimilar Drugs Market

32.1. Brazil Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oral Biologics & Biosimilar Drugs Market

33.1. Middle East Oral Biologics & Biosimilar Drugs Market Overview

33.2. Middle East Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oral Biologics & Biosimilar Drugs Market

34.1. Africa Oral Biologics & Biosimilar Drugs Market Overview

34.2. Africa Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oral Biologics & Biosimilar Drugs Market Regulatory and Investment Landscape

36. Oral Biologics & Biosimilar Drugs Market Competitive Landscape And Company Profiles

36.1. Oral Biologics & Biosimilar Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oral Biologics & Biosimilar Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oral Biologics & Biosimilar Drugs Market Company Profiles

36.3.1. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Rani Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

37. Oral Biologics & Biosimilar Drugs Market Other Major And Innovative Companies

Biocon Limited, Oramed Pharmaceuticals Inc., BiosanaPharma, Entera Bio Ltd., Allergan plc, Emisphere Technologies Inc., Enteris BioPharma Inc., Chiasma Inc., Allena Pharmaceuticals Inc., Gelgen Corporation, 3SBio Inc., Innovent Biologics Inc., GlaxoSmithKline PLC, Concord Biotech Limited, Sanofi S.A.

38. Global Oral Biologics & Biosimilar Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oral Biologics & Biosimilar Drugs Market

40. Oral Biologics & Biosimilar Drugs Market High Potential Countries, Segments and Strategies

40.1 Oral Biologics & Biosimilar Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Oral Biologics & Biosimilar Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Oral Biologics & Biosimilar Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Oral Biologics & Biosimilar Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Oral Biologics & Biosimilar Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Oral Biologics & Biosimilar Drugs Market, Supply Chain Analysis

Table 4: Global Oral Biologics & Biosimilar Drugs Market, Major Raw Material Providers

Table 5: Global Oral Biologics & Biosimilar Drugs Market, Major Resource Providers

Table 6: Global Oral Biologics & Biosimilar Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Oral Biologics & Biosimilar Drugs Market, Major Distributors And Channel Partners

Table 8: Global Oral Biologics & Biosimilar Drugs Market, Key Technologies & Future Trends

Table 9: Global Oral Biologics & Biosimilar Drugs Market, Major Trends

Table 10: Global Oral Biologics & Biosimilar Drugs Market, Major End Users

Table 11: Global Oral Biologics & Biosimilar Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Oral Biologics & Biosimilar Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Oral Biologics & Biosimilar Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Oral Biologics & Biosimilar Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Lymphocyte Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Tumor Necrosis Factor-Alpha Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Oral Biologics & Biosimilar Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Oral Biologics & Biosimilar Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Oral Biologics & Biosimilar Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Oral Biologics & Biosimilar Drugs Market - Company Scoring Matrix

Table 98: Novartis International AG Financial Performance

Table 99: Rani Therapeutics Holdings Inc. Financial Performance

Table 100: Eli Lilly and Company Financial Performance

Table 101: AstraZeneca plc Financial Performance

Table 102: Novo Nordisk A/S Financial Performance

Table 103: Global Oral Biologics & Biosimilar Drugs Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Oral Biologics & Biosimilar Drugs Market, Competitive Dashboard

Table 105: Global Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Table 107: Global, Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Table 108: Global, Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), Segmentation By Molecule Type, 2025 – 2030

List Of Figures

Figure 1: Global Oral Biologics & Biosimilar Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Oral Biologics & Biosimilar Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Oral Biologics & Biosimilar Drugs Market, Supply Chain Analysis

Figure 4: Global Oral Biologics & Biosimilar Drugs Market, Major Raw Material Providers

Figure 5: Global Oral Biologics & Biosimilar Drugs Market, Major Resource Providers

Figure 6: Global Oral Biologics & Biosimilar Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Oral Biologics & Biosimilar Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Oral Biologics & Biosimilar Drugs Market, Key Technologies & Future Trends

Figure 9: Global Oral Biologics & Biosimilar Drugs Market, Major Trends

Figure 10: Global Oral Biologics & Biosimilar Drugs Market, Major End Users

Figure 11: Global Oral Biologics & Biosimilar Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Oral Biologics & Biosimilar Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Oral Biologics & Biosimilar Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Oral Biologics & Biosimilar Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Lymphocyte Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Oral Biologics & Biosimilar Drugs Market, Sub-Segmentation Of Tumor Necrosis Factor-Alpha Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Oral Biologics & Biosimilar Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Oral Biologics & Biosimilar Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Oral Biologics & Biosimilar Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Oral Biologics & Biosimilar Drugs Market - Company Scoring Matrix

Figure 98: Novartis International AG Financial Performance

Figure 99: Rani Therapeutics Holdings Inc. Financial Performance

Figure 100: Eli Lilly and Company Financial Performance

Figure 101: AstraZeneca plc Financial Performance

Figure 102: Novo Nordisk A/S Financial Performance

Figure 103: Global Oral Biologics & Biosimilar Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Oral Biologics & Biosimilar Drugs Market, Competitive Dashboard

Figure 105: Global Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Figure 107: Global, Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Figure 108: Global, Oral Biologics & Biosimilar Drugs Market Size Gain ($ Billion), Segmentation By Molecule Type, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Dental Practice Management Market Report 2026 - Global Outlook – By Deployment Mode (Web-Based, Cloud-Based, On-Premise), By Application (Patient Communication Software, Invoice/Billing Software, Payment Processing Softw...

Dental X-Ray Equipment Market Report 2026 - Global Outlook – By Type (Extraoral X-Ray Systems, Intraoral X-Ray Systems, Hybrid X-Ray Systems), By Technology (Digital, Analog), By Application (Cosmetics, Medical, Forensic...

Dental Diagnostic Imaging Devices And Equipment Market Report 2026 - Global Outlook – By Method (Intraoral Imaging, Extraoral Imaging), By Technology (X-Ray Systems, Dental Cone Beam Computed Tomography, Optical Dental I...

Dental Equipment And Supplies Market Report 2026 - Global Outlook – By Type (Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices An...

Therapeutic Dental Equipment Market Report 2026 - Global Outlook – By Product (Soft Tissue Lasers, All Tissue Lasers), By End User (Hospitals, Clinics, Dental laboratories), By Therapeutic Area (Restorative Dentistry, Or...

Biologics Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines ), By Drug Classification (Branded Drugs, Generic Drugs ), By Route Of Administration (Oral, Other Rou...

Biosimilars Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones), By Protein Type (Recombinant Non-glycosylated Proteins, R...

Frequently Asked Questions

How big is the Oral Biologics & Biosimilar Drugs Market?

The Oral Biologics & Biosimilar Drugs market was valued at $8.6 billion in 2025, increased to $10.41 billion in 2026, and is projected to reach $17.17 billion by 2030.

What is the Oral Biologics & Biosimilar Drugs market growth?

The global Oral Biologics & Biosimilar Drugs market is expected to grow at a CAGR of 13.3% from 2026 to 2035 to reach $17.17 billion by 2035.

Who are the key players in Oral Biologics & Biosimilar Drugs market?

Some Key Players in the Oral Biologics & Biosimilar Drugs market Include, Novartis International AG, Rani Therapeutics Holdings Inc., Eli Lilly and Company, AstraZeneca plc, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals Inc., BiosanaPharma, Entera Bio Ltd., Allergan plc, Emisphere Technologies Inc., Enteris BioPharma Inc., Chiasma Inc., Allena Pharmaceuticals Inc., Gelgen Corporation, 3SBio Inc., Innovent Biologics Inc., GlaxoSmithKline PLC, Concord Biotech Limited, Sanofi S.A., F. Hoffmann-La Roche Ltd., Allergan Pharmaceuticals International Limited, Mylan N.V., Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd. .

What is the anticipated growth trend for the Oral Biologics & Biosimilar Drugs market?

Major trend in this market includes: Advancements In Oral Biologics For Obesity Management. For further insights on this market. request a sample here

Which region has the most growth potential in the Oral Biologics & Biosimilar Drugs market?

North America was the largest region in the oral biologics and biosimilar drugs market in 2025. The Middle East is expected to be the fastest growing region in the oral biologics & biosimilar drugs market report during the forecast period. The regions covered in the oral biologics & biosimilar drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.